Table of Content



Introduction
Cytomegalovirus (HHV-5) Infections - Overview
Cytomegalovirus (HHV-5) Infections - Therapeutics Development
Cytomegalovirus (HHV-5) Infections - Therapeutics Assessment
Cytomegalovirus (HHV-5) Infections - Companies Involved in Therapeutics Development
Cytomegalovirus (HHV-5) Infections - Drug Profiles
Cytomegalovirus (HHV-5) Infections - Dormant Projects
Cytomegalovirus (HHV-5) Infections - Discontinued Products
Cytomegalovirus (HHV-5) Infections - Product Development Milestones
Appendix



List of Figures


List of Figures
Number of Products under Development for Cytomegalovirus (HHV-5) Infections, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Number of Products by Top 10 Targets, 2021
Number of Products by Stage and Top 10 Targets, 2021
Number of Products by Top 10 Mechanism of Actions, 2021
Number of Products by Stage and Top 10 Mechanism of Actions, 2021
Number of Products by Routes of Administration, 2021
Number of Products by Stage and Routes of Administration, 2021
Number of Products by Top 10 Molecule Types, 2021
Number of Products by Stage and Top 10 Molecule Types, 2021

List of Tables


List of Tables
Number of Products under Development for Cytomegalovirus (HHV-5) Infections, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Companies, 2021 (Contd..1)
Number of Products under Development by Companies, 2021 (Contd..2)
Number of Products under Development by Universities/Institutes, 2021
Number of Products under Development by Universities/Institutes, 2021 (Contd..1)
Products under Development by Companies, 2021
Products under Development by Companies, 2021 (Contd..1)
Products under Development by Companies, 2021 (Contd..2)
Products under Development by Companies, 2021 (Contd..3)
Products under Development by Universities/Institutes, 2021
Products under Development by Universities/Institutes, 2021 (Contd..1)
Number of Products by Stage and Target, 2021
Number of Products by Stage and Target, 2021 (Contd..1)
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Cytomegalovirus (HHV-5) Infections - Pipeline by Abhelix LLC, 2021
Cytomegalovirus (HHV-5) Infections - Pipeline by AlloVir Inc, 2021
Cytomegalovirus (HHV-5) Infections - Pipeline by AlphaVax Inc, 2021
Cytomegalovirus (HHV-5) Infections - Pipeline by Artemis Therapeutics Inc, 2021
Cytomegalovirus (HHV-5) Infections - Pipeline by Biotest AG, 2021
Cytomegalovirus (HHV-5) Infections - Pipeline by Chengdu Rongsheng Pharmaceutical Co Ltd, 2021
Cytomegalovirus (HHV-5) Infections - Pipeline by China Biologic Products Holdings Inc, 2021
Cytomegalovirus (HHV-5) Infections - Pipeline by China Immunotech Co Ltd, 2021
Cytomegalovirus (HHV-5) Infections - Pipeline by Citranvi Biosciences LLC, 2021
Cytomegalovirus (HHV-5) Infections - Pipeline by Danuvius BioSciences, 2021
Cytomegalovirus (HHV-5) Infections - Pipeline by Evrys Bio, 2021
Cytomegalovirus (HHV-5) Infections - Pipeline by GlaxoSmithKline Plc, 2021
Cytomegalovirus (HHV-5) Infections - Pipeline by Helocyte Biosciences Inc, 2021
Cytomegalovirus (HHV-5) Infections - Pipeline by Hookipa Pharma Inc, 2021
Cytomegalovirus (HHV-5) Infections - Pipeline by Huinuo Biomedical Technology Co Ltd, 2021
Cytomegalovirus (HHV-5) Infections - Pipeline by iCELL Biotechnology Co Ltd, 2021
Cytomegalovirus (HHV-5) Infections - Pipeline by Karyopharm Therapeutics Inc, 2021
Cytomegalovirus (HHV-5) Infections - Pipeline by Memo Therapeutics AG, 2021
Cytomegalovirus (HHV-5) Infections - Pipeline by Merck & Co Inc, 2021
Cytomegalovirus (HHV-5) Infections - Pipeline by Microbiotix Inc, 2021
Cytomegalovirus (HHV-5) Infections - Pipeline by Moderna Inc, 2021
Cytomegalovirus (HHV-5) Infections - Pipeline by Nobelpharma Co Ltd, 2021
Cytomegalovirus (HHV-5) Infections - Pipeline by Okogen Inc, 2021
Cytomegalovirus (HHV-5) Infections - Pipeline by Orgenesis Inc, 2021
Cytomegalovirus (HHV-5) Infections - Pipeline by Phoenix Biotechnology Inc, 2021
Cytomegalovirus (HHV-5) Infections - Pipeline by Prosit Sole Biotechnology (Beijing) Co Ltd, 2021
Cytomegalovirus (HHV-5) Infections - Pipeline by Provention Bio Inc, 2021
Cytomegalovirus (HHV-5) Infections - Pipeline by Savoy Pharmaceuticals Inc, 2021
Cytomegalovirus (HHV-5) Infections - Pipeline by Shanxi Kangbao Biological Product Co Ltd, 2021
Cytomegalovirus (HHV-5) Infections - Pipeline by SL VaxiGen Inc, 2021
Cytomegalovirus (HHV-5) Infections - Pipeline by SpyBiotech Ltd, 2021
Cytomegalovirus (HHV-5) Infections - Pipeline by Stadius Biopharma LLC, 2021
Cytomegalovirus (HHV-5) Infections - Pipeline by Synklino ApS, 2021
Cytomegalovirus (HHV-5) Infections - Pipeline by Takeda Pharmaceutical Co Ltd, 2021
Cytomegalovirus (HHV-5) Infections - Pipeline by Themis Bioscience GmbH, 2021
Cytomegalovirus (HHV-5) Infections - Pipeline by Trellis Bioscience Inc, 2021
Cytomegalovirus (HHV-5) Infections - Pipeline by VBI Vaccines Inc, 2021
Cytomegalovirus (HHV-5) Infections - Pipeline by Vichem Chemie Research Ltd, 2021
Cytomegalovirus (HHV-5) Infections - Pipeline by Viramatix Sdn Bhd, 2021
Cytomegalovirus (HHV-5) Infections - Pipeline by Zhuhai Trinomab Biotechnology Co Ltd, 2021
Cytomegalovirus (HHV-5) Infections - Dormant Projects, 2021
Cytomegalovirus (HHV-5) Infections - Dormant Projects, 2021 (Contd..1)
Cytomegalovirus (HHV-5) Infections - Dormant Projects, 2021 (Contd..2)
Cytomegalovirus (HHV-5) Infections - Dormant Projects, 2021 (Contd..3)
Cytomegalovirus (HHV-5) Infections - Dormant Projects, 2021 (Contd..4)
Cytomegalovirus (HHV-5) Infections - Discontinued Products, 2021